Upfront Alternative Donor Transplant versus Immunosuppressive Therapy in Patients with Severe Aplastic Anemia Who Lack a Fully HLA-Matched Related Donor: Systematic Review and Meta-Analysis of Retrospective Studies, on Behalf of the Severe Aplastic Anemia Working Party of the European Group for Blood and Marrow Transplantation
Open Access
- 1 February 2022
- journal article
- review article
- Published by Elsevier in Transplantation and Cellular Therapy
- Vol. 28 (2) , 105.e1-105.e7
Abstract
No abstract availableKeywords
This publication has 32 references indexed in Scilit:
- First-line treatment for severe aplastic anemia in children: bone marrow transplantation from a matched family donor versus immunosuppressive therapyHaematologica, 2014
- Horse versus Rabbit Antithymocyte Globulin in Acquired Aplastic AnemiaNew England Journal of Medicine, 2011
- Decreased Infection-Related Mortality and Improved Survival in Severe Aplastic Anemia in the Past Two DecadesClinical Infectious Diseases, 2011
- Impact of age on outcomes after bone marrow transplantation for acquired aplastic anemia using HLA-matched sibling donorsHaematologica, 2010
- Fludarabine, cyclophosphamide, antithymocyte globulin, with or without low dose total body irradiation, for alternative donor transplants, in acquired severe aplastic anemia: a retrospective study from the EBMT-SAA working partyHaematologica, 2010
- Guidelines for the diagnosis and management of aplastic anaemiaBritish Journal of Haematology, 2009
- Overcoming graft rejection in heavily transfused and allo‐immunised patients with bone marrow failure syndromes using fludarabine‐based haematopoietic cell transplantationBritish Journal of Haematology, 2006
- Antithymocyte Globulin and Cyclosporine for Severe Aplastic AnemiaJAMA, 2003
- Cyclophosphamide and antithymocyte globulin to condition patients with aplastic anemia for allogeneic marrow transplantations: The experience in four centersTransplantation and Cellular Therapy, 2001
- Bone marrow transplantation (BMT) versus immunosuppression for the treatment of severe aplastic anaemia (SAA): a report of the EBMT* SAA Working PartyBritish Journal of Haematology, 1988